Ishita Drugs & Industries share news and announcements

BSE: 524400Pharmaceuticals & BiotechnologySmall Cap

₹70.01₹2.74 (3.77%)

Share price at the BSE close on 23 Oct 2026. Previous close ₹72.75.

52-week range of traded prices to 23 Oct 2026

₹66.00Low, 13 Jan 2026₹90.85High, 29 Dec 2025

Market cap: ₹21 Cr4,064th largest listed
P/E: 29.6
P/B: 1.8
Dividend yield: Nonein the last 12 months
ROE: 6.3%
ROCE: 5.3%
Debt to equity: 0.01
Volume, BSE: 211

Ishita Drugs & Industries share news and announcements

525 announcements, routine notices left out, newest first. Page 3 of 11.

Aug 2024
- 13 Aug · Board meeting
  Approval of the Unaudited Financial Results of the Company for the quarter ended 30th June, 2024. the limited review repot issued by statutory auditor of the company attached herewith. (opens in a new tab)
- 13 Aug · Board meeting
  Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e.13th August, 2024 have 1. Approved the Unaudited Financial Results of the Company for the quarter .... (opens in a new tab)
- 7 Aug · Board meeting
  Meeting on 13 Aug 2024: quarterly results
- 7 Aug · Board meeting
  ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 ,inter alia, to consider and approve 1. To consider, .... (opens in a new tab)
Jun 2024
May 2024
- 30 May · Board meeting
  Outcome of Board Meeting held on 30th May, 2024 (opens in a new tab)
- 30 May · Board meeting
  Board of Directors of Ishita Drugs and Industries Limited, at its Board Meeting held on Thursday, 30th May, 2024, inter-alia, considered the following matters: 1. Considered and approved .... (opens in a new tab)
- 23 May · Board meeting
  Meeting on 30 May 2024: audited results
- 23 May · Board meeting
  ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 ,inter alia, to consider and approve the following business: 1. .... (opens in a new tab)
- 22 May · Non Applicability Of Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  We hereby confirm that the Company has not raised any funds by the means of public issue, right issue, preferential issue or QIPs etc., during the financial year ended March 31, 2024. (opens in a new tab)
Apr 2024
- 22 Apr · Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2024
  We are enclosing the certificate received from Ms. Meenu Maheshwari, Practicing Company Secretary pursuant to the Regulation 40(9) and 40(10) of the SEBI (Listing Obligations and Disclosure .... (opens in a new tab)
- 11 Apr · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2024
  Pursuant to the requirement of Regulation 7(2) & 7 (3) of SEBI(LODR) Regulations, 2015, Please find enclosed herewith Compliance Certificate received from our RTA, for the financial year .... (opens in a new tab)
- 8 Apr · Meeting
  Revised - Proceedings of the 30th Annual General Meeting held on 27th September, 2023. (opens in a new tab)
Mar 2024
Feb 2024
- 13 Feb · Board meeting
  Approval of Unaudited Financial Results with Limited Review Report issued by Statutory Auditor of the Company for the quarter ended 31st December, 2023. (opens in a new tab)
- 13 Feb · Board meeting
  Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e.13th February, 2024 have 1. Approved the Unaudited Financial Results with Limited Review Report .... (opens in a new tab)
- 2 Feb · Board meeting
  Meeting on 13 Feb 2024: quarterly results
- 2 Feb · Board meeting
  ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2024 ,inter alia, to consider and approve the following business: 1. .... (opens in a new tab)
Nov 2023
- 8 Nov · Board meeting
  Approval of Unaudited Financial Results with Limited Review Report issued by statutory auditor of the Company for the quarter ended 30th September, 2023. (opens in a new tab)
- 8 Nov · Board meeting
  Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e.8th November, 2023 have 1. Approved the Unaudited Financial Results with Limited Review Report .... (opens in a new tab)
Oct 2023
- 31 Oct · Board meeting
  Meeting on 8 Nov 2023: quarterly results
- 31 Oct · Board meeting
  ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve the following business: 1. .... (opens in a new tab)
Sep 2023
Aug 2023
- 29 Aug · Meeting
  This is to inform you that the 30th Annual General Meeting(AGM) of the Company will be held on Wednesday, 27th September, 2023 and the E voting period for AGM commence on Sunday, 24th September, .... (opens in a new tab)
- 28 Aug · INTIMATION OF E- VOTING AS PER THE REGULATION 44 OF SEBI (LODR) REGULATION, 2015
  This is to inform you that the Company has fixed Wednesday, 20th September, 2023, as the cut-off date to determine the entitlement of voting rights of members for e-voting in the ensuing .... (opens in a new tab)
- 28 Aug · Meeting
  We wish to inform you that the Register of Members and share transfer book of the Company will remain closed from 21st September, 2023 to 27th September, 2023(both days inclusive) for the .... (opens in a new tab)
- 12 Aug · Results
  Approval of Unaudited Financial Results with the Limited Review report issued by the Statutory Auditor of the Company for the quarter ended 30th June, 2023. (opens in a new tab)
- 12 Aug · Results
  Board of Directors of Ishita Drugs and Industries Limited, at its meeting held today i.e.12th August, 2023 have 1. Approved the Unaudited Financial Results with Limited Review Report issued .... (opens in a new tab)
- 3 Aug · Board meeting
  Meeting on 12 Aug 2023: quarterly results
- 3 Aug · Board meeting
  ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 ,inter alia, to consider and approve the following business: 1. .... (opens in a new tab)
Jul 2023
- 6 Jul · Compliance-57 (5) : intimation after the end of quarter
  Non-Applicability of Regulation 57(5) of SEBI (LODR) Regulations, 2015 for the quarter ended 30th June, 2023. (opens in a new tab)
Jun 2023
- 10 Jun · Board meeting
  We hereby submit the Revised Outcome of Board Meeting held on 30th May, 2023 (opens in a new tab)
- 10 Jun · Board meeting
  We hereby Resubmit the Revised Outcome of Board Meeting held on 30th May, 2023 (opens in a new tab)
May 2023
- 30 May · Results
  Approved the Audited Financial Results of the Company for the quarter and year ended 31st March, 2023 (opens in a new tab)
- 30 May · Results
  Board of Directors of Ishita Drugs and Industries Limited, at its Board Meeting held on Tuesday, 30th May, 2023, inter-alia, considered the following matters: 1. Approved the .... (opens in a new tab)
- 23 May · Board meeting
  Meeting on 30 May 2023: audited results
- 23 May · Board meeting
  ISHITA DRUGS & INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve the following business: 1.To .... (opens in a new tab)
- 11 May · Non Applicability Of Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
  We hereby confirm that the Company has not raised any fund by the means of public issue, right issue, preferential issue, or QIP, during the financial year ended March 31, 2023. (opens in a new tab)
Apr 2023
- 14 Apr · Compliance Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2023
  We are enclosing the certificate received from Ms. Meenu Maheshwari, Practicing Company Secretary pursuant to the Regulation 40(9) and 40(10) of the SEBI (Listing Obligations and Disclosure .... (opens in a new tab)
- 11 Apr · Submission Of Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended 31St March, 2023.
  Pursuant to the requirement of Regulation 7(2) & 7(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, submission of Compliance Certificate received from our RTA, .... (opens in a new tab)
- 7 Apr · Compliance-57 (5) : intimation after the end of quarter
  Certificate of Non- applicability of Regulation 57(5) of SEBI (LODR) Regulations, 2015 for the quarter ended 31st March, 2023. (opens in a new tab)
- 1 Apr · Business
  Disclosures Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for Ishita Drugs and Industries LTD. received from Abha Agrawal. (opens in a new tab)
- 1 Apr · Business
  Disclosures Under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for Ishita Drugs and Industries LTD. received from Abha Agrawal. (opens in a new tab)
Feb 2023
- 14 Feb · Results
  We wish to inform you that the Board of Directors of Ishita Drugs and .... (opens in a new tab)

Ishita Drugs & Industries share news and announcements

Aug 2024

Jun 2024

May 2024

Apr 2024

Mar 2024

Feb 2024

Nov 2023

Oct 2023

Sep 2023

Aug 2023

Jul 2023

Jun 2023

May 2023

Apr 2023

Feb 2023